Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer

Summary

A phase 2 study to evaluate efficacy of oral seliciclib in treating non-small cell lung cancer (NSCLC).

Timeline

Start

2006-08-09

Primary completion

2009-03-03

Completion

2009-04-07

Publications

• Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009 Mar;9(3):153-66. doi: 10.1038/nrc2602.

Drugs

Indications